RecruitingNCT05466851

An Exploratory Study Examining Biopsychosocial Markers of Anxiety and Depression


Sponsor

Singula Institute

Enrollment

200 participants

Start Date

Mar 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This research study is studying how thoughts, feelings, surroundings, and individual biology may contribute to why and how people experience anxiety or depression. We are trying to find out the wide variety of reasons that people may experience anxiety or depression, and why different people are helped by different forms of treatment. We are trying to determine why people stay in treatment, and what factors contribute to a positive or negative response to treatment. These reasons may be due to thoughts, feelings, beliefs, personality, biology, social support network, life events, and barriers to treatment. A wide range of information about factors that impact anxiety and depression will be included. These include, among others, measures of inflammation, hormone levels, behavior, spoken language, personality, medical history, social determinants of health, and attitudes toward mental health and its treatment. The study involves psychological and psychiatric treatments in the form of psychotherapy and medication management. The participant will be asked to set specific goals for study treatment, and to provide videos between sessions about relevant medication, emotional, and sleep factors in their life. In summary, this study will collect biological, psychological, and social factors that may play a role in anxiety and depression. This will inform both individual's diagnosis and treatment and will be used in a later set of analyses that can inform diagnosis and treatment for other individuals who share similar characteristics.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring biological and psychological markers in people with depression and anxiety to better understand these conditions and improve treatment. **You may be eligible if...** - You are 18 to 65 years old - You have been diagnosed with Major Depression (single episode or recurring) - You may also have an anxiety condition such as Panic Disorder, Social Anxiety, Generalized Anxiety, OCD, PTSD, or ADHD - You are willing to participate in medication and/or therapy treatment **You may NOT be eligible if...** - You have a serious unstable medical condition (heart, liver, kidney, lung, neurological, or blood disease) - You have a history of head trauma or stroke - You have used opioid medications in the past 12 months - You tested positive for HIV - You have psychosis, schizophrenia, or another psychotic disorder - You have had a drug or alcohol dependency in the past 12 months - You are currently considered a serious risk for suicide or harm to others Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Singula Institute, 353 Lexington Avenue (Room 600)

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05466851


Related Trials